Sonoma BioTherapeutics Investors

25 investors on Angel Roster list Sonoma BioTherapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, China and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Sonoma BioTherapeutics can appear together.

Investors listed
25
With verified email
44%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 25 Sonoma BioTherapeutics investors

The most complete profiles first. Showing 25 of 25.

  • Carol SuhVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • David CruikshankVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHardware

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • JinVerified

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedEnterprise SoftwareTransportation

    Portfolio: FreightWeb, Motherly, Cellino Biotech, Nylas and 80 more

    Verified email available

  • Katie ElliasVerified

    Venture Capital, Investor · United States

    SeedAngularJSEducationBiotechnologyElectronic Health Records (EHR)

    Portfolio: Tetragenetics, Biolinq, Enthera, Provention Bio and 19 more

    Verified email available

  • Kimmy ScottiVerified

    Venture Capital, Founder, Private Equity Firm · United States

    Series BHealth CareWomen FoundedEnterprise SoftwareTransportation

    Portfolio: Fruitful, FreightWeb, Motherly, Cellino Biotech and 82 more

    Verified email available

  • Sean KendallVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareEnterprise SoftwareEnergyChemical

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Wesley FriedmanVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BHealth CareWomen FoundedEnterprise SoftwareTransportation

    Portfolio: FreightWeb, Motherly, Cellino Biotech, Nylas and 80 more

    Verified email available

  • Fei ChenVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Judith LiVerified

    Venture Capital · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Verified email available

  • Mark McDonnellVerified

    Venture Capital · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Tom BrennanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Yi ShiVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Verified email available

  • Corey Ritter

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceRoboticsManufacturing

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Francisco Gimenez

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BHealth CareWomen FoundedEnterprise SoftwareTransportation

    Portfolio: FreightWeb, Motherly, Cellino Biotech, Nylas and 81 more

    Contact details available

  • Jake Medwell

    Venture Capital, Advisor, Founder · United States

    Series BHealth CareAutonomous VehiclesWomen FoundedEnterprise Software

    Portfolio: FreightWeb, Motherly, Cellino Biotech, Nylas and 85 more

    Contact details available

  • John Tenet

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareTransportation

    Portfolio: FreightWeb, Motherly, Cellino Biotech, Nylas and 80 more

    Contact details available

  • Nilay Thakar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Sebastian Caliri

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BHealth CareWomen FoundedEnterprise SoftwareTransportation

    Portfolio: FreightWeb, Motherly, Cellino Biotech, Nylas and 81 more

    Contact details available

  • Steve Gillis

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more

    Contact details available

  • Steven St. Peter, M.D.

    Venture Capital, Investor · United States

    SeedBiotechnologyPharmaceuticals

    Portfolio: Tetragenetics, EKR Therapeutics, Biolinq, Enthera and 20 more

    Contact details available

  • Jieyu Zou

    Venture Capital · China

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Ling Su

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Robert Nelsen

    Venture Capital, Investor · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more

    Contact details available

  • Stacey Olson

    Venture Capital · United States

    Health CareWomen FoundedEnterprise SoftwareTransportation

    Portfolio: FreightWeb, Motherly, Cellino Biotech, Nylas and 80 more

    Contact details available

  • Yury Kukushkin

    Venture Capital · United States

    Portfolio: Tetragenetics, Biolinq, Enthera, Provention Bio and 19 more

    Contact details available

Frequently asked questions

How many Sonoma BioTherapeutics investors are on Angel Roster?

Angel Roster lists 25 Sonoma BioTherapeutics investors. 11 of them (44%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (25), Private Equity Firms (9) and Finance Operator Investors (5). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Sonoma BioTherapeutics investors invest in?

Among those that list a stage, the most common are Series B (12), Seed (3) and Pre-Seed (1).

Where are Sonoma BioTherapeutics investors based?

Most are based in the United States (19), China (4) and the United Kingdom (1).

Which companies have Sonoma BioTherapeutics investors backed?

The most-backed portfolio companies among them are Mindstrong (17), Resilience (17), KSQ Therapeutics (14), Qihan Biotech (14) and Singleron Biotechnologies (14).

How do I contact Sonoma BioTherapeutics investors?

Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.